Search Results

You are looking at 101 - 110 of 1,721 items for :

  • "introduction" x
  • Refine by Access: All x
Clear All
Free access

Jang R. Liu

Commercial sources of biotechnology have enormously outweighted non-market sources (e.g. the International Agricultural Research Center) Thus it is most obvious that growing R&D costs and intensified internationa technology competition have financially disabled developing countries from access to the new technology. Furthermore, biotechnology is a typica interdisciplinary subject based on many different principles of newly developed life sciences such as biochemistry, physiology, microbiology and molecular biology, which limits number of personnel in developing countries who are capable of incorporating the new technological inovation o developed countries into their agricultural production system. The protection of intellectual property rights (IPRs) of which private firms in developed countries have intensified put another limiting factor in the international flow of biotechnology. Financial aid, technical assistance for personnel training and execution of self-restrained IPRs towards developing countries wil enable developed countries widen the potential market and contribute to sustainable development in the Third World.